Rice is a key partner on Project Metis, a groundbreaking initiative led by Center for Houston’s Future to position the Houston-Galveston region as the global leader in brain health and the emerging brain economy.
A new study led by researchers at Rice360 Institute for Global Health Technologies evaluated the accuracy and reliability of 11 commonly available point-of-care glucometers to determine which could safely be adapted for neonatal care in resource-constrained settings.
Rice materials scientist and neuroengineer Christina Tringides has been named a Distinguished Scientist by the Sontag Foundation, a national recognition for early career researchers advancing transformative projects in brain cancer research.
Rice bioengineers have designed an erasable serum marker that could enable clinicians to detect problems or measure any changes in how a patient responds to treatment with greater precision, using simple, minimally-invasive testing.
As artificial intelligence plays an increasingly prominent role in decoding DNA, tracking pathogens and accelerating drug discovery, the line between real capability and hype can be unclear. Rice experts can provide clear, technically grounded perspectives on how these tools are meaningfully advancing disease detection, public health preparedness and treatment design.
Rice has launched the Amyloid Mechanism and Disease Center, a new campus hub dedicated to uncovering the molecular origins of Alzheimer’s, Parkinson’s and other amyloid-related diseases.
More than 600 investors, entrepreneurs and industry leaders gathered at Rice Business Nov. 11 for the 14th annual Texas Life Science Forum, co-hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship. The event highlighted Houston’s growing leadership in life science innovation, commercialization and venture investment.
Researchers at Rice and Oak Ridge National Laboratory have unveiled a physics-based model of magnetic resonance relaxation that bridges molecular-scale dynamics with macroscopic magnetic resonance imaging (MRI) signals, promising new insight into how contrast agents interact with water molecules.
Rice bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit using a method that merges ultrasound, gene therapy and chemogenetics.
A team of researchers from Rice and the Houston Methodist Research Institute has received a John S. Dunn Foundation Collaborative Research Award through the Gulf Coast Consortia to study how the brain responds over time to neural implants.